[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627173":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":34,"centralContacts":39,"locations":11,"responsibleParty":48,"collaborators":11,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":11,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":11,"enrollmentInfo":61,"targetDuration":11,"studyType":64,"phases":65,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":73,"whyStopped":11,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":11},{"fullName":5,"class":6},"Cairo University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Saline","ACTIVE_COMPARATOR",null,[13],"Drug: Saline",{"label":15,"type":16,"description":11,"interventionNames":17},"Triamcinolone with lidocaine","EXPERIMENTAL",[18],"Drug: Triamcinolone with lidocaine",{"label":20,"type":16,"description":11,"interventionNames":21},"Lidocaine",[22],"Drug: Lidocaine",[24,28,31],{"type":25,"name":9,"description":26,"armGroupLabels":27,"otherNames":11},"DRUG","Patients will take 1 ml of lidocaine 2%",[9],{"type":25,"name":15,"description":29,"armGroupLabels":30,"otherNames":11},"Patients will take 1 ml of active drug mix (1\u002F4 ml of Triamcinolone and 3\u002F4 ml of lidocaine)",[15],{"type":25,"name":20,"description":32,"armGroupLabels":33,"otherNames":11},"Patients will take 1 ml lidocaine 2%",[20],[35],{"name":36,"affiliation":37,"role":38},"Hamida Refai Hasanien Hasanien Hamida Refai Hasanien, phd","cair university","STUDY_DIRECTOR",[40,45],{"name":41,"role":42,"phone":43,"phoneExt":11,"email":44},"Ammar Ali Mudhsh Al-Hawbani Ammar Ali Mudhsh Al-Hawbani, bachelor's degree","CONTACT","0103052078","prof.hamidarefaee@gmail.com",{"name":46,"role":42,"phone":47,"phoneExt":11,"email":11},"Hamida Refai Hasanien Hasanien professor, phd","01013052078",{"type":49,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Ammar Ali Mudhsh Al hawbani","AAMAHawbani","100627173","phase-2-efficacy-of-triamcinolone-lidocaine-mix-in-trigger-points-injection-of-masseter-muscle-double-blinded-randomized-controlled-trial-100627173",false,"NCT07445191","Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial","Clinical Assessment of The Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial","Inclusion criteria\n\n1. Age more than or equal 18 years\n2. Both sexes\n3. Patients' willingness to follow instructions\n\nExclusion criteria\n\n1. Patients who will be using any medications to reduce the pain and\u002For have any effect on the skeletal muscle\n2. Clinical conditions such as pregnancy\n3. Medical problems that may interfere with the procedures such as bleeding disorders\n4. Cognitive impairment or exhibited inadequate cooperation\n5. Patients will be receiving physical therapy or wearing occlusal splint in the same period of the research","ALL","18 Years",{"count":62,"type":63},30,"ESTIMATED","INTERVENTIONAL",[66,67],"PHASE2","PHASE3","This study aims to clinically evaluate the efficacy of trigger points using active drug mix (Triamcinolone with lidocaine) on relief of myofascial pain of jaw muscle.",[70],"TMJ Pain",[72],"masseter muscle","NOT_YET_RECRUITING","2026-02-28",{"date":76,"type":77},"2026-03-03","ACTUAL",{"date":79,"type":63},"2026-03-01",{"date":81,"type":63},"2026-07-01",{"name":5,"class":6}]